Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Stockholm - Delayed Quote SEK

Hansa Biopharma AB (publ) (HNSA.ST)

Compare
21.70
-0.94
(-4.15%)
At close: April 4 at 5:29:46 PM GMT+2

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 32.34M
Earnings -276.42M

Q1'24

Q2'24

Q3'24

Q4'24

-200M
-100M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

32.00
85.25 Average
21.70 Current
143.00 High

Earnings Estimate

Currency in SEK Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 3344
Avg. Estimate -2.61-2.44-9.58-8.75
Low Estimate -3.47-3.37-14.24-15.93
High Estimate -1.95-1.75-7.17-5.96
Year Ago EPS -4.15-3.3-12.84-9.58

Revenue Estimate

Currency in SEK Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 3344
Avg. Estimate 54.96M70.94M295.22M475.98M
Low Estimate 50.94M65.9M224.93M429.53M
High Estimate 62M81M412M523.31M
Year Ago Sales 56M34.3M171.32M295.22M
Sales Growth (year/est) -1.85%106.83%72.33%61.23%

Earnings History

Currency in SEK 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. -3.46-2.78-2.42-1.98
EPS Actual -4.15-3.3-1.53-4.08
Difference -0.69-0.520.89-2.1
Surprise % -19.94%-18.71%36.69%-106.06%

EPS Trend

Currency in SEK Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate -2.61-2.44-9.58-8.75
7 Days Ago -1.77-1.68-9.42-8.22
30 Days Ago -1.77-1.68-7.47-5.49
60 Days Ago -1.94-1.86-7.47-5.49
90 Days Ago -1.94-1.86-7.37-5.49

EPS Revisions

Currency in SEK Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 22----
Up Last 30 Days 22----
Down Last 7 Days ----11
Down Last 30 Days ----33

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
HNSA.ST 37.19%26.06%25.37%8.66%
S&P 500 6.68%6.74%9.91%14.34%

Related Tickers